SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:umu-203552"
 

Sökning: id:"swepub:oai:DiVA.org:umu-203552" > European Associatio...

  • Hoang-Xuan, KhêAPHP, Department of Neurology, Groupe Hospitalier Pitié-Salpêtrière; Sorbonne Université; IHU; ICM. Paris, France (författare)

European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • 2022-08-12
  • Oxford University Press,2023
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:umu-203552
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-203552URI
  • https://doi.org/10.1093/neuonc/noac196DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • The management of primary central nervous system (PCNSL) is one of the most controversial topics in neuro-oncology because of the complexity of the disease and the limited number of controlled studies available. In 2021, given recent advances and the publication of practice-changing randomized trials, the European Association of Neuro-Oncology (EANO) created a multidisciplinary task force to update the previously published evidence-based guidelines for immunocompetent adult patients with PCNSL and added a section on immunosuppressed patients. The guideline provides consensus considerations and recommendations for the treatment of PCNSL, including intraocular manifestations and specific management of the elderly. The main changes from the previous guideline include strengthened evidence for the consolidation with ASCT in first-line treatment, prospectively assessed chemotherapy combinations for both young and elderly patients, clarification of the role of rituximab even though the data remain inconclusive, of the role of new agents, and the incorporation of immunosuppressed patients and primary ocular lymphoma. The guideline should aid the clinicians in everyday practice and decision making and serve as a basis for future research in the field.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Deckert, MartinaInstitute of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany (författare)
  • Ferreri, Andrés J MLymphoma Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy (författare)
  • Furtner, JuliaDepartment of Biomedical and Imaging Image-guided Therapy Medical University of Vienna, Vienna, Austria (författare)
  • Gallego Perez-Larraya, JaimeHealth Research Institute of Navarra (IdiSNA), Program in Solid Tumors, Foundation for the Applied Medical Research, Department of Neurology, Clinica Universidad de Navarra, Pamplona, Navarra, Spain (författare)
  • Henriksson, RogerUmeå universitet,Onkologi(Swepub:umu)rohe0003 (författare)
  • Hottinger, Andreas F.Department of Oncology and Clinical Neurosciences, CHUV University Hospital Lausanne and University of Lausanne (författare)
  • Kasenda, BenjaminDepartment of Hematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany (författare)
  • Lefranc, FlorenceDepartment of Neurosurgery, Hôpital Erasme, Université Libre de Bruxelles, Belgium (författare)
  • Lossos, AlexanderHead, Leslie and Michael Gaffin Center for Neuro-Oncology; Department of Oncology and Neurology; Hadassah-Hebrew University Medical Center; Jerusalem, Israel (författare)
  • McBain, CatherineDepartment of Clinical Oncology, The Christie NHS FT; Manchester; United Kingdom (författare)
  • Preusser, MatthiasDivision of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria (författare)
  • Roth, PatrickDepartment of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland (författare)
  • Rudà, RobertaDepartment of Neurology, Castelfranco Veneto/Treviso Hospital, Italy; Division of Neuro-Oncology, Department of Neuroscience, University of Turin, City of Health and Science University Hospital, Turin, Italy (författare)
  • Schlegel, UweUniversitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Germany (författare)
  • Soffietti, RiccardoDivision of Neuro-Oncology, Department of Neuroscience, University of Turin, City of Health and Science University Hospital, Turin, Italy (författare)
  • Soussain, CaroleDepartment of Hematology, Institut Curie, Site Saint-Cloud, PSL Research University, Paris, France (författare)
  • Taphoorn, Martin J BDepartment of Neurology, Leiden University Medical Center and Department of Neurology, Haaglanden Medical Center The Hague, Netherlands (författare)
  • Touitou, ValérieAPHP, Department of Ophtalmology, Groupe Hospitalier Pitié-Salpêtrière; Sorbonne Université. Paris, France (författare)
  • Weller, MichaelDepartment of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland (författare)
  • Bromberg, Jacoline E CDepartment of Neuro-Oncology, Erasmus MC University Medical Center Cancer Institute, Netherlands (författare)
  • APHP, Department of Neurology, Groupe Hospitalier Pitié-Salpêtrière; Sorbonne Université; IHU; ICM. Paris, FranceInstitute of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Neuro-Oncology: Oxford University Press25:1, s. 37-531522-85171523-5866

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy